Introduction to Epidemiology

Concept	Definition	Formula (Simplified)	Example
Incidence	The number of new cases of a disease in a population at risk during a specified time period.		In a town of 10,000 disease-free people, 50 develop flu in a year: Incidence
Prevalence	The total number of existing cases (new + old) of a disease in a population at a given point in time.		In the same town, on a specific day, 150 people have the flu: Prevalence
Morbidity	The state of being diseased or the incidence of illness in a population. Often measured by incidence or prevalence rates.	N/A	The morbidity rate for diabetes is rising.
Mortality	The number of deaths in a population from a specific cause or from all causes.		In 2020, the COVID-19 mortality rate was 85 per 100,000 in Country X.

Notes:

• k is a scaling factor (e.g., 1,000; 10,000; or 100,000), depending on context.
• Incidence measures risk (new cases), while prevalence measures burden (existing cases).
• Morbidity reflects illness frequency, and mortality reflects death rates.

Crucial Distinction:

• Incidence is a measure of risk (how likely a healthy person is to get the disease).
• Prevalence is a measure of burden (how much disease exists in the population).
• Relationship: Prevalence ≈ Incidence × Average Duration of Disease. A long-lasting disease (e.g., diabetes) has high prevalence even if incidence is low. A short-term disease (e.g., common cold) has high incidence but low prevalence at any point.

Types of Epidemiological Studies

Epidemiological inquiry progresses through three distinct phases: describing the problem, analyzing its causes, and finally testing solutions. These phases guide researchers in their pursuit of understanding health-related phenomena. Below is the general flow of this process:

• Best for studying rare diseases or those with long latency periods.
• Best for establishing causality and studying multiple outcomes.
• Provides a 'snapshot' of a population at one point in time.

Phase 1: Descriptive Epidemiology

• Objective: Seeks to describe the patterns of disease and health outcomes based on Person, Place, and Time.
• Purpose: This phase is used to generate hypotheses that could explain the patterns observed.
• Key focus: Describes who, what, where, and when of the disease in question.

Phase 2: Analytical Epidemiology

• Objective: Seeks to analyze causes and test hypotheses generated during the descriptive phase.
• Purpose: This phase is crucial for identifying risk factors and testing the potential causes behind the observed patterns.

Key Questions:

• What is the best method to test the hypothesis?
• How can we determine if a factor causes the disease or outcome?

Types of Studies in Analytical Epidemiology:

• Case-Control Studies (Retrospective):
  • Best for: Studying rare diseases or conditions that have long latency periods.
  • How it works: Compares people with the disease (cases) to people without the disease (controls) to identify potential risk factors.
• Cohort Studies (Prospective or Retrospective):
  • Best for: Studying the effects of exposures over time, especially for conditions with long latency periods.
  • How it works: Follows a group of individuals (cohort) who are exposed to a potential risk factor and another group who are not, tracking the outcomes over time.
• Cross-Sectional Studies (Prevalence Studies):
  • Best for: Providing a snapshot of the population at a specific point in time to estimate disease prevalence.
  • How it works: Measures the proportion of the population affected by a disease or condition at a particular moment.

Phase 3: Experimental Epidemiology

• Objective: Seeks to intervene and prove causality.
• Purpose: This phase aims to test the impact of interventions and establish definitive cause-and-effect relationships. It is considered the ‘Gold Standard’ in epidemiological research.

Key Study Design:

• Randomized Controlled Trials (RCTs):
  • How it works: Individuals are randomly assigned to either the intervention group (which receives the treatment) or the control group (which does not). This design helps determine if the intervention causes the outcome.
  • Best for: Establishing a clear cause-and-effect relationship between an exposure (e.g., treatment) and an outcome.

In summary, the flow of epidemiological studies can be broken down into:

1. Descriptive Epidemiology – Describes patterns and generates hypotheses.
2. Analytical Epidemiology – Tests hypotheses and analyzes causes.
3. Experimental Epidemiology – Intervenes to prove causality.

A. Measures of Disease Frequency

1. Incidence Rate

• Definition: The speed at which new cases of a disease occur in a population over a period of time.
• Formula:

Note: Person-time (e.g., person-years) is used in the denominator to account for the varying observation times.

2. Attack Rate

• Definition: A specific type of incidence rate used during an outbreak, focusing on a defined, short-term population.
• Formula:

Example: Often used in outbreaks (e.g., flu, foodborne illnesses).

3. Mortality Rate

• Definition: The proportion of deaths due to a specific disease in a given population over a specified time period.
• Formula:

Where k is a constant (e.g., 1,000, 100,000) for scaling.

B. Measures of Association (Used in Analytical Studies)

These measures compare groups to determine whether an exposure is linked to an outcome (such as disease). The key measures are Relative Risk (RR), Odds Ratio (OR), and Attributable Risk (AR).

Measure	Calculation	Interpretation
Relative Risk (RR) (Used in Cohort Studies)		- RR = 1: No association between exposure and outcome.  - RR > 1: Positive association (e.g., RR = 3 means the exposed group has 3x the risk).  - RR < 1: Negative association (protective factor).
Odds Ratio (OR) (Used in Case-Control Studies)	(From a 2x2 table)	Interpreted similarly to RR. Represents the odds of exposure among cases compared to the odds of exposure among controls.
Attributable Risk (AR) (or Risk Difference)		Measures the excess risk of disease in the exposed group attributable to the exposure. This shows the potential impact of removing the exposure (i.e., the risk reduction if the exposure were eliminated).

Summary of Key Measures:

• Relative Risk (RR) is used in Cohort Studies to compare the risk of disease between exposed and unexposed groups. A RR > 1 indicates a positive association, suggesting that the exposure increases the risk of the disease.
• Odds Ratio (OR) is commonly used in Case-Control Studies and represents the odds of exposure among those with the disease (cases) versus those without the disease (controls). OR > 1 indicates a positive association.

Attributable Risk (AR) shows the extra risk in the exposed group that can be attributed to the exposure itself, providing insights into how much of the disease burden in the exposed group is due to the exposure

The 2x2 Table: The Basis for Calculation

• Risk in Exposed = a / (a+b)
• Risk in Unexposed = c / (c+d)
• Relative Risk (RR) = [a/(a+b)] / [c/(c+d)]
• Odds Ratio (OR) = (a/c) / (b/d) = (a×d) / (b×c)

How do we know if an association is causal? Bradford Hill's Criteria provide a set of guidelines:

1. Strength of Association: Large RR or OR.
2. Consistency: The association is found in multiple studies by different researchers.
3. Specificity: The exposure leads to a single specific outcome.
4. Temporality: The exposure must precede the outcome. (This is the only absolute requirement).
5. Biological Gradient: A dose-response relationship (higher exposure = higher risk).
6. Plausibility: A plausible biological mechanism exists.
7. Coherence: The association does not conflict with known facts about the disease.
8. Experiment: Evidence from a controlled experiment supports the association.
9. Analogy: The effect is similar to that of another known causal agent.

Summary: The Epidemiological Approach

Epidemiology is the fundamental science of public health. Its practice follows a logical sequence:

1. Describe the health event (Who? Where? When?) using descriptive studies and measures like prevalence.
2. Generate Hypotheses about potential causes.
3. Test these hypotheses using analytical studies (cohort, case-control) and measures like RR and OR.
4. Prove Causality by evaluating the evidence against criteria like Bradford Hill's, ideally supported by experimental studies (RCTs).
5. Intervene by developing and implementing public health policies and programs based on the evidence.
6. Evaluate the effectiveness of the interventions through further surveillance and study.

This continuous cycle from description to action is what allows epidemiology to control disease and improve population health.